(V472) |
Exon-skipping as a novel therapeutic approach for titin-based dilated cardiomyopathy |
|
M. Gramlich, Q. Zhou, L. Zha, S. Schötterl, M. Gawaz (Tübingen) |
(V473) |
Suppression of p27kip1 contributes to Eya4-mediated development of acquired cardiac hypertrophy |
|
T. Williams, M. Hundertmark, D. Kraemer, J. Schönberger, P. Nordbeck, S. Voll, M. Czolbe, V. Pekarek, O. Ritter (Würzburg; Bern, CH) |
(V474) |
Single-Target RNA Interference Blocks Multiple Proinflammatory and Profibrotic Pathways in Human Cardiofibroblasts and Provides Evidence of a Novel Link Between Inflammation and Fibrosis |
|
J. Tank, D. Lindner, L. Gilke, X. Wang, U. Kühl, C. Skurk, C. Tschöpe, H.-P. Schultheiss, D. Westermann, W. Poller (Berlin) |
(V475) |
Biological heart rate reduction through genetic suppression of Gαs protein in the sinoatrial node |
|
P. Lugenbiel, A. Bauer, K. Kelemen, P. Schweizer, R. Becker, H. A. Katus, D. Thomas (Heidelberg, Schwäbisch Hall) |
(V476) |
Functional interaction of osteogenic transcription factors Runx2 and Vdr in transcriptional regulation of osteopontin (Opn) expression during soft tissue calcification in MRP6 deficient mice |
|
A.-K. Sowa, F. Kaiser, E. Juliana, S. Wrobel, L. Doehring, H. Schunkert, J. Erdmann, Z. Aherrahrou (Lübeck) |
(V477) |
The Raf kinase inhibitor protein (RKIP) preserves calcium cycling and cardiac integrity in a mouse model of inherited human heart failure |
|
S. Denzinger, J. Schmitt, M. Lohse, K. Lorenz (Würzburg) |